Johnson & Johnson(JNJ)
Drug Manufacturers - General · New Brunswick, NJ
$269.12+0.00 (+0.00%)
Delayed quote: Sep 8, 2026, 4:00 PM EDT
Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 8, 2026, 4:00 PM EDT
The latest quarterly cash is $20.42 Billion with a quarter-over-quarter change of -5.84%. Cash and cash equivalents include currency, bank deposits, and highly liquid investments that can be quickly converted to cash.
Reported quarterly cash and cash equivalents; no daily interpolation.
$20.42B
$20.42 Billion
-5.84%
vs. $21.69B prior quarter
96
Quarters of data available
| Period | Cash | QoQ Change | % Change |
|---|---|---|---|
| Quarter ended Jun 2026 | $20.42B | −$1.27B | -5.84% |
| Quarter ended Mar 2026 | $21.69B | +$1.98B | +10.04% |
| Quarter ended Dec 2025 | $19.71B | +$1.48B | +8.11% |
| Quarter ended Sep 2025 | $18.23B | −$346.00M | -1.86% |
| Quarter ended Jun 2025 | $18.58B | −$19.90B | -51.72% |
| Quarter ended Mar 2025 | $38.47B | +$14.37B | +59.61% |
| Quarter ended Dec 2024 | $24.11B | +$4.13B | +20.65% |
| Quarter ended Sep 2024 | $19.98B | −$4.90B | -19.69% |
| Quarter ended Jun 2024 | $24.88B | −$595.00M | -2.34% |
| Quarter ended Mar 2024 | $25.47B | +$3.61B | +16.53% |
| Quarter ended Dec 2023 | $21.86B | +$2.13B | +10.80% |
| Quarter ended Oct 2023 | $19.73B | −$1.46B | -6.87% |
| Quarter ended Jul 2023 | $21.18B | +$2.01B | +10.50% |
| Quarter ended Apr 2023 | $19.17B | +$6.28B | +48.73% |
| Quarter ended Dec 2022 | $12.89B | +$1.53B | +13.51% |
| Quarter ended Oct 2022 | $11.36B | +$372.00M | +3.39% |
| Quarter ended Jul 2022 | $10.98B | +$520.00M | +4.97% |
| Quarter ended Apr 2022 | $10.46B | −$4.02B | -27.78% |
| Quarter ended Dec 2021 | $14.49B | −$3.12B | -17.71% |
| Quarter ended Oct 2021 | $17.60B | +$3.27B | +22.83% |
| Quarter ended Jul 2021 | $14.33B | +$1.66B | +13.11% |
| Quarter ended Apr 2021 | $12.67B | −$1.31B | -9.40% |
| Quarter ended Dec 2020 | $13.98B | −$4.98B | -26.26% |
| Quarter ended Sep 2020 | $18.96B | +$7.79B | +69.72% |
| Quarter ended Jun 2020 | $11.17B | −$4.36B | -28.05% |
| Quarter ended Mar 2020 | $15.53B | −$1.77B | -10.26% |
| Quarter ended Dec 2019 | $17.30B | +$1.06B | +6.50% |
| Quarter ended Sep 2019 | $16.25B | +$1.87B | +13.03% |
| Quarter ended Jun 2019 | $14.38B | −$358.00M | -2.43% |
| Quarter ended Mar 2019 | $14.73B | −$3.37B | -18.63% |
| Quarter ended Dec 2018 | $18.11B | +$2.05B | +12.77% |
| Quarter ended Sep 2018 | $16.06B | −$1.51B | -8.61% |
| Quarter ended Jul 2018 | $17.57B | +$2.93B | +20.02% |
| Quarter ended Apr 2018 | $14.64B | −$3.19B | -17.87% |
| Quarter ended Dec 2017 | $17.82B | +$2.10B | +13.38% |
| Quarter ended Oct 2017 | $15.72B | +$3.12B | +24.79% |
| Quarter ended Jul 2017 | $12.60B | −$8.31B | -39.75% |
| Quarter ended Apr 2017 | $20.91B | +$1.94B | +10.21% |
| Quarter ended Dec 2016 | $18.97B | +$767.00M | +4.21% |
| Quarter ended Oct 2016 | $18.20B | −$435.00M | -2.33% |
| Quarter ended Jul 2016 | $18.64B | +$4.78B | +34.48% |
| Quarter ended Apr 2016 | $13.86B | +$129.00M | +0.94% |
| Quarter ended Dec 2015 | $13.73B | +$93.00M | +0.68% |
| Quarter ended Sep 2015 | $13.64B | +$3.00B | +28.20% |
| Quarter ended Jun 2015 | $10.64B | −$1.35B | -11.25% |
| Quarter ended Mar 2015 | $11.99B | −$2.54B | -17.46% |
| Quarter ended Dec 2014 | $14.52B | +$705.00M | +5.10% |
| Quarter ended Sep 2014 | $13.82B | −$418.00M | -2.94% |
| Quarter ended Jun 2014 | $14.24B | −$5.49B | -27.82% |
| Quarter ended Mar 2014 | $19.72B | −$1.21B | -5.76% |
| Quarter ended Dec 2013 | $20.93B | +$3.72B | +21.64% |
| Quarter ended Sep 2013 | $17.20B | −$103.00M | -0.60% |
| Quarter ended Jun 2013 | $17.31B | +$2.45B | +16.51% |
| Quarter ended Mar 2013 | $14.86B | −$56.00M | -0.38% |
| Quarter ended Dec 2012 | $14.91B | −$575.00M | -3.71% |
| Quarter ended Sep 2012 | $15.49B | +$1.44B | +10.28% |
| Quarter ended Jul 2012 | $14.04B | −$16.23B | -53.61% |
| Quarter ended Apr 2012 | $30.27B | +$5.72B | +23.33% |
| Quarter ended Dec 2011 | $24.54B | +$8.93B | +57.15% |
| Quarter ended Oct 2011 | $15.62B | +$643.00M | +4.29% |
| Quarter ended Jul 2011 | $14.97B | −$7.38B | -33.02% |
| Quarter ended Apr 2011 | $22.36B | +$3.00B | +15.51% |
| Quarter ended Dec 2010 | $19.36B | +$5.02B | +34.99% |
| Quarter ended Oct 2010 | $14.34B | +$1.63B | +12.78% |
| Quarter ended Jul 2010 | $12.71B | −$1.03B | -7.49% |
| Quarter ended Apr 2010 | $13.74B | −$2.07B | -13.07% |
| Quarter ended Dec 2009 | $15.81B | +$3.95B | +33.35% |
| Quarter ended Sep 2009 | $11.86B | +$170.00M | +1.45% |
| Quarter ended Jun 2009 | $11.69B | −$903.00M | -7.17% |
| Quarter ended Mar 2009 | $12.59B | +$1.82B | +16.91% |
| Quarter ended Dec 2008 | $10.77B | −$3.25B | -23.18% |
| Quarter ended Sep 2008 | $14.02B | +$1.37B | +10.85% |
| Quarter ended Jun 2008 | $12.65B | +$2.11B | +19.99% |
| Quarter ended Mar 2008 | $10.54B | +$2.77B | +35.64% |
| Quarter ended Dec 2007 | $7.77B | +$1.13B | +17.02% |
| Quarter ended Sep 2007 | $6.64B | +$1.07B | +19.19% |
| Quarter ended Jul 2007 | $5.57B | +$396.00M | +7.65% |
| Quarter ended Apr 2007 | $5.17B | +$1.09B | +26.75% |
| Quarter ended Dec 2006 | $4.08B | −$10.41B | -71.82% |
| Quarter ended Oct 2006 | $14.49B | −$156.00M | -1.07% |
| Quarter ended Jul 2006 | $14.65B | −$2.17B | -12.93% |
| Quarter ended Apr 2006 | $16.82B | +$767.00M | +4.78% |
| Quarter ended Dec 2005 | $16.05B | +$1.23B | +8.30% |
| Quarter ended Oct 2005 | $14.82B | +$2.67B | +21.96% |
| Quarter ended Jul 2005 | $12.16B | +$3.62B | +42.36% |
| Quarter ended Apr 2005 | $8.54B | −$664.00M | -7.22% |
| Quarter ended Dec 2004 | $9.20B | +$1.85B | +25.24% |
| Quarter ended Sep 2004 | $7.35B | +$1.67B | +29.34% |
| Quarter ended Jun 2004 | $5.68B | +$44.00M | +0.78% |
| Quarter ended Mar 2004 | $5.64B | +$260.00M | +4.84% |
| Quarter ended Dec 2003 | $5.38B | +$1.53B | +39.66% |
| Quarter ended Sep 2003 | $3.85B | +$882.00M | +29.72% |
| Quarter ended Jun 2003 | $2.97B | −$93.00M | -3.04% |
| Quarter ended Mar 2003 | $3.06B | +$167.00M | +5.77% |
| Quarter ended Dec 2002 | $2.89B | −$267.00M | -8.45% |
| Quarter ended Sep 2002 | $3.16B | N/A | N/A |